The article from NCQA on 09/25/2026 titled “Why Liver Health Belongs in the Cardiometabolic Conversation” argues that liver health belongs in routine cardiometabolic care. Obesity, type 2 diabetes, high blood pressure, and abnormal cholesterol often occur alongside fatty liver disease. Liver disease can quietly worsen for years, even when a person feels well and routine liver enzymes are normal.
For people at risk, the article recommends checking for advanced liver scarring with a FIB-4 blood-test calculation, then using a second test, such as a liver stiffness measurement, when indicated. Care should address weight, blood sugar, blood pressure, cholesterol, and alcohol use together. The article is a Novo Nordisk–sponsored guest contribution, rather than an NCQA clinical guideline.
